Leucine

Private

LEUCINE MEDTECH PRIVATE LIMITED

Private

LEUCINE MEDTECH PRIVATE LIMITED

2019

Founded in 2019, Leucine operates in Enterprise Tech industry. Initially focused on innovative solutions for the pharma sector, the company now offers comprehensive manufacturing services for pharmace...

Funding stage:

Series A

Last funding:

15/10/2023

Total funding:

$7.00 Mn+

Revenue:

₹1.4 Cr+ (FY25)

Prev. FY

Investors

Employee count:

114

Last 90d

114

Last 90d

Web traffic:

9.63K

Last 30d

Glassdoor Rating:

Leucine: Financial Breakdown

Decoding financial health metrics of Leucine

Total Revenue
₹1.4 Cr
775%
Prev. FY
Total Expenses
₹1.4 Cr
2882%
Prev. FY
Profit After Tax
₹-2.8 Lakh
-125%
Prev. FY
Total Assets
₹1.9 Cr
38%
Prev. FY
Net Profit Margin
-2.0%
-103%
Prev. FY

Note: Above mentioned stats are for FY24-25

FAQs on Financials of Leucine

No. In FY25, Leucine reported a net loss of ₹2.8 Lakh, so it was not profitable.

Leucine's revenue grew 775.6% year-on-year, from ₹16.2 Lakh in FY24 to ₹1.4 Cr in FY25.

In FY25, Leucine posted revenue of ₹1.4 Cr (up 775.6% YoY) and a net loss of ₹2.8 Lakh. Explore the full financials of Leucine here...

Disclaimer

Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.

Quick Links

Leucine - Financials, Revenue, P&L Statement, Balance Sheet, Cash Flow & More

Leucine: Financial Breakdown

FAQs on Financials of Leucine

Is Leucine profitable?

What is Leucine's growth rate?

How is Leucine's business performing?

Disclaimer